Cite
Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML.
MLA
Strachan, Debbie C., et al. “Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML.” Cancers, vol. 14, no. 24, Dec. 2022, p. 6240. EBSCOhost, https://doi.org/10.3390/cancers14246240.
APA
Strachan, D. C., Gu, C. J., Kita, R., Anderson, E. K., Richardson, M. A., Yam, G., Pimm, G., Roselli, J., Schweickert, A., Terrell, M., Rashid, R., Gonzalez, A. K., Oviedo, H. H., Alozie, M. C., Ilangovan, T., Marcogliese, A. N., Tada, H., Santaguida, M. T., & Stevens, A. M. (2022). Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML. Cancers, 14(24), 6240. https://doi.org/10.3390/cancers14246240
Chicago
Strachan, Debbie C., Christine J. Gu, Ryosuke Kita, Erica K. Anderson, Michelle A. Richardson, George Yam, Graham Pimm, et al. 2022. “Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML.” Cancers 14 (24): 6240. doi:10.3390/cancers14246240.